Altimmune (ALT) Short-Term Debt issuances (2012 - 2014)
Altimmune (ALT) reported Short-Term Debt issuances of -$1.1 million for Q1 2014, down 85593.88% year-over-year from N/an in Q1 2013, and down 200.0% quarter-over-quarter from $1.1 million in Q4 2013.
Altimmune (ALT) Short-Term Debt issuances (2012 - 2014) Analysis & Trends
Altimmune (ALT) has 3 years of Short-Term Debt issuances data on file, last reported at -$1.1 million in Q1 2014.
- Short-Term Debt issuances for Q1 2014 came in at -$1.1 million, down 85593.88% year-over-year; the trailing twelve-month figure through Dec 2014 was -$1.1 million (down 357.24% YoY), and the FY2014 annual result was -$1.1 million, down 357.24% from the prior year.
- Short-Term Debt issuances slipped to -$1.1 million in Q1 2014 per ALT's latest filing, from $1.1 million in the prior quarter.
- Over five years, Short-Term Debt issuances peaked at $1.1 million in Q4 2013 and troughed at -$1.2 million in Q3 2013.
- A 3-year average of -$50080.3 and a median of -$1274.0 in 2013 frame the typical range for Short-Term Debt issuances.
- The sharpest annual moves came in 2013 and 2014: Short-Term Debt issuances soared 793.87% in 2013, then sank 85593.88% in 2014.
- A 3-year view of Short-Term Debt issuances shows it stood at $122137.0 in 2012, then soared by 793.87% to $1.1 million in 2013, then sank by 200.0% to -$1.1 million in 2014.
- Business Quant data shows ALT's Short-Term Debt issuances at -$1.1 million in Q1 2014, $1.1 million in Q4 2013, and -$1.2 million in Q3 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -33,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | -1.09 Mn |
| Mar 31, 2014 | -1.09 Mn |
| Dec 31, 2013 | 1.09 Mn |
| Dec 31, 2013 | 1.09 Mn |
| Sep 30, 2013 | -1.17 Mn |
| Sep 30, 2013 | -1.17 Mn |
| Jun 30, 2013 | -161,090.00 |
| Jun 30, 2013 | -161,090.00 |
| Mar 31, 2013 | -1,274.00 |
| Mar 31, 2013 | -1,274.00 |
| Dec 31, 2012 | 122,137.00 |
| Dec 31, 2012 | 122,137.00 |
| Mar 31, 2012 | 857,808.00 |
| Mar 31, 2012 | 857,808.00 |